Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Glycogen storage disease type II")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectorsMAH, C; CRESAWN, K. O; FRAITES, T. J et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 18, pp 1405-1409, issn 0969-7128, 5 p.Article

Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe diseaseHOEKSMA, Marieke; BOON, Maartje; NIEZEN-KONING, Klary E et al.European journal of pediatrics. 2007, Vol 166, Num 8, pp 871-874, issn 0340-6199, 4 p.Article

The Role of Immune Tolerance Induction in Restoration of the Efficacy of ERT in Pompe DiseaseLACANA, Emanuela; YAO, Lynne P; PARISER, Anne R et al.American journal of medical genetics. Part C, Seminars in medical genetics. 2012, Vol 160, Num 1, pp 30-39, issn 1552-4868, 10 p.Article

Newborn Screening for Pompe Disease: An Update, 2011BURTON, Barbara K.American journal of medical genetics. Part C, Seminars in medical genetics. 2012, Vol 160, Num 1, pp 8-12, issn 1552-4868, 5 p.Article

Adult onset glycogen storage disease type II (adult onset Pompe disease): report and magnetic resonance images of two casesDEL GAIZO, Andrew; BANERJEE, Sima; TERK, Michael et al.Skeletal radiology. 2009, Vol 38, Num 12, pp 1205-1208, issn 0364-2348, 4 p.Article

Improved Exercise Tolerance after Enzyme Replacement Therapy in Pompe DiseaseMARZORATI, Mauro; PORCELLI, Simone; REGGIORI, Barbara et al.Medicine and science in sports and exercise. 2012, Vol 44, Num 5, pp 771-775, issn 0195-9131, 5 p.Article

Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutationsOBA-SHINJO, Sueli M; DA SILVA, Roseli; MUNOZ, Verônica et al.Journal of neurology. 2009, Vol 256, Num 11, pp 1881-1890, issn 0340-5354, 10 p.Article

Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe diseaseTHURBERG, Beth L; MALONEY, Colleen Lynch; VACCARO, Charles et al.Laboratory investigation. 2006, Vol 86, Num 12, pp 1208-1220, issn 0023-6837, 13 p.Article

Pompe Disease: Early Diagnosis and Early Treatment Make a DifferenceCHIEN, Yin-Hsiu; HWU, Wuh-Liang; LEE, Ni-Chung et al.Pediatrics & neonatology (Print). 2013, Vol 54, Num 4, pp 219-227, issn 1875-9572, 9 p.Article

Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe diseaseSUN, B; LI, S; BIRD, A et al.Gene therapy (Basingstoke). 2010, Vol 17, Num 12, pp 1500-1505, issn 0969-7128, 6 p.Article

Identification of four novel mutations in the alpha glucosidase gene in five Italian patients with infantile onset glycogen storage disease type IIPITTIS, Maria Gabriela; MONTALVO, Anna Lisa E; MIOCIC, Snjezana et al.American journal of medical genetics. 2003, Vol 121A, Num 3, pp 225-230, issn 0148-7299, 6 p.Article

EXPANDING THE PHENOTYPE OF LATE-ONSET POMPE DISEASE: TONGUE WEAKNESS: A NEW CLINICAL OBSERVATIONDUBROVSKY, Alberto; CORDERI, Jose; LIN, Min et al.Muscle & nerve. 2011, Vol 44, Num 6, pp 897-901, issn 0148-639X, 5 p.Article

  • Page / 1